This assay may be useful for detecting antibodies specific for swine HEV and is more economical than current commercially available ELISA kits. in the present study appears to be both practical and economical. Keywords:diagnosis, ELISA, swine hepatitis E virus == Introduction == Hepatitis E virus (HEV) is a significant global public health issue because this virus causes an enterically transmitted form of viral hepatitis in humans [7,18]. The mortality rate associated with hepatitis E is less than 1% in the general population, but can reach up to 28% in pregnant women [18]. HEV infection is endemic in developing countries [genotype 1 (Asia and Africa), genotype 4 (Asia), or genotype 2 (Mexico and Africa)] in areas with poor sanitation and hygiene standards, and causes medium- to large-sized waterborne epidemics with sporadic cases of acute hepatitis [3,16]. In developed countries (genotype 3), viral infection is primarily found among travelers who have visited disease-endemic regions [4,16,25]. HEV may also be more prevalent than previously thought in industrialized countries [5]. The occurrence of zoonotic infection in non-endemic areas has been reported more frequently, and the incidence of chronic HEV Piperlongumine infection in transplant recipients in industrialized countries is rising [19,22]. In addition, the number of animal species infected with HEV is increasing worldwide and now includes pigs, chickens, and several wild species [16]. Among these, pigs are particularly important zoonotic reservoirs because swine HEV is genetically similar to the human strain, and much information is available about HEV infection transmitted by infected pigs [8,15]. Presently, the seroprevalence of anti-HEV IgG is 39.5% and 80% in individual pigs and swine herds, respectively [14]. The prevalence of anti-HEV antibodies in the adult Korean population is about 20% with a higher prevalence among older individuals [23]. These data represent a significant increase compared to that previously reported [2,4]. Thus, the concern about zoonotic infection is increasing [18,20]. Although several diagnostic methods have been developed and used to identify hepatitis E virus infection, establishment of new assays with superior performance characteristics such as enhanced efficacy and cost-effectiveness is required [1]. Commercial kits are available for identifying HEV based on the detection of short ORF2 and ORF3 fragments of genotypes 1 and 2 [21]. These assays detect anti-HEV antibodies in human sera or plasma but they might have lower sensitivity for identifying infections with genotype 3 strains, the most prevalent genotype among swine and humans in industrialized countries [14]. Various reports have indicated that commercial assays may also fail to detect specific antibodies in sera from patients with proven HEV genotype 3 infection [6,14,27]. Furthermore, commercial ELISA kits are also very expensive for routine testing and the secondary antibody for the kits Rabbit Polyclonal to Collagen V alpha1 needs to be substituted with an anti-pig antibody to detect swine HEV. These considerations suggest the need for more sensitive, specific, simple, standardized, and low-cost assays to detect swine HEV. In the present study, an ELISA was developed that uses a recombinant capsid protein, which is the most immunogenic portion of the HEV. The efficacy of this ELISA was evaluated using pig sera obtained in the field. == Materials and Methods == == Viral RNA and cDNA synthesis == All reagents for isolating viral RNA and PCR amplification were purchased from Invitrogen (USA). Pig sera were obtained from jugular vein of pigs in Korean pig farms and isolated with centrifugation at 750 g for 10 min. Piperlongumine HEV viral RNA was purified from pig sera using Trizol LS reagent (Invitrogen) according to the manufacturer’s instructions. The viral RNA was eluted with a total volume of 30 L RNase-free water and stored at -70 until further analysis. cDNA was synthesized using an external reverse primer specific for the capsid gene of HEV and M-MLV (moloney murine leukemia virus) Reverse Transcriptase. Briefly, 10 L of viral RNA and 1 L of external reverse primer (2 pmol/L) were mixed, incubated at 70 for 10 min, and chilled at 4 for 5 min. This mixture was Piperlongumine added to 4 L of 5 First Strand Buffer that contained 2 L of 0.1 M DTT (dithiothreitol), 1 L of 10 mM dNTP mixture, 1 L of RNase free water, 0.5 L of RNaseOUT RNA inhibitor, and 0.5 L of M-MLV Reverse Transcriptase. The samples were incubated at 37 for 1.5 h, 70 for 10 min, and 4 for 5 min before being stored at -20. == PCR and cloning the capsid gene == Two-step PCR amplification was performed using cDNA made from HEV isolated from swine serum as previously described [2]. The nested forward primer sequence was slightly.